{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:02:23Z","timestamp":1761886943045,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.oftale.2023.11.014","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T12:06:32Z","timestamp":1700913992000},"page":"62-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitreous rebleeding rate after vitrectomy or phacovitrectomy in patients with proliferative diabetic retinopathy: A retrospective study"],"prefix":"10.1016","volume":"99","author":[{"given":"S.","family":"Garc\u00eda-Luna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.Y.","family":"Pita-Ort\u00edz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.U.","family":"Quevedo-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Somilleda-Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"P\u00e9rez-Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2023.11.014_bib0005","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oftale.2023.11.014_bib0010","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/jdi.13480","article-title":"Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy","volume":"12","author":"Lin","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.oftale.2023.11.014_bib0015","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1167\/iovs.17-22920","article-title":"Nrf2 activation is a potential therapeutic approach to attenuate diabetic retinopathy","volume":"59","author":"Deliyanti","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftale.2023.11.014_bib0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/IAE.0000000000003070","article-title":"Need for a new classification of diabetic retinopathy","volume":"41","author":"Jampol","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oftale.2023.11.014_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.freeradbiomed.2016.12.030","article-title":"Epigenetic regulation of redox signaling in diabetic retinopathy: role of Nrf2","volume":"103","author":"Kowluru","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.oftale.2023.11.014_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2021.101140","article-title":"Proliferative diabetic retinopathy (PDR)","volume":"67","author":"Chaudhary","year":"2021","journal-title":"Dis Mon"},{"key":"10.1016\/j.oftale.2023.11.014_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oftale.2023.11.014_bib0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00055735-199406000-00009","article-title":"Diabetic vitrectomy","volume":"5","author":"Reichel","year":"1994","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.014_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/ojo.OJO_105_2019","article-title":"Vitrectomy versus phaco-vitrectomy","volume":"12","author":"Al-Hinai","year":"2019","journal-title":"Oman J Ophthalmol"},{"year":"2022","series-title":"Vitreous hemorrhage","author":"Jena","key":"10.1016\/j.oftale.2023.11.014_bib0050"},{"key":"10.1016\/j.oftale.2023.11.014_bib0055","doi-asserted-by":"crossref","first-page":"725","DOI":"10.21149\/12842","article-title":"Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020","volume":"63","author":"Basto-Abreu","year":"2021","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.oftale.2023.11.014_bib0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.icu.0000193098.28798.18","article-title":"Diabetic vitrectomy: risks, prognosis, future trends","volume":"17","author":"Mason","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.014_bib0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ajo.2012.11.004","article-title":"Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy","volume":"155","author":"Khuthaila","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.014_bib0070","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/02713680903572491","article-title":"Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy","volume":"35","author":"Yan","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oftale.2023.11.014_bib0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0021-5155(99)00194-X","article-title":"Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy","volume":"44","author":"Sawa","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.oftale.2023.11.014_bib0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.21037\/apm.2020.01.10","article-title":"Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy","volume":"9","author":"Chen","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.oftale.2023.11.014_bib0085","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/IAE.0b013e3181a3b7ef","article-title":"Bevacizumab pretreatment in vitrectomy with silicone oil for severe diabetic retinopathy","volume":"29","author":"Yeh","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.oftale.2023.11.014_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008214.pub2","article-title":"Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy","author":"Smith","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.oftale.2023.11.014_bib0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.12669\/pjms.341.12683","article-title":"Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab a comparative overview","volume":"34","author":"Faisal","year":"2018","journal-title":"Pak J Med Sci"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579423001913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579423001913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:29:33Z","timestamp":1761881373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579423001913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2173579423001913"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2023.11.014","relation":{},"ISSN":["2173-5794"],"issn-type":[{"type":"print","value":"2173-5794"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitreous rebleeding rate after vitrectomy or phacovitrectomy in patients with proliferative diabetic retinopathy: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2023.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2023.11.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}